{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:57:41Z","timestamp":1792785461889,"version":"4.5.0"},"reference-count":32,"publisher":"Informa UK Limited","issue":"12","license":[{"start":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T00:00:00Z","timestamp":1778371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T00:00:00Z","timestamp":1778371200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"Pfizer Inc"},{"name":"Astellas Pharma Inc","id":[{"id":"https:\/\/ror.org\/01cjash87","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncology"],"published-print":{"date-parts":[[2026,5,15]]},"DOI":"10.1080\/14796694.2026.2667441","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T05:19:42Z","timestamp":1778476782000},"page":"1397-1408","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Phase III randomized studies of mevrometostat and enzalutamide in metastatic prostate cancer (MEVPRO-1 and MEVPRO-2): trial protocols"],"prefix":"10.1080","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5767-0548","authenticated-orcid":false,"given":"Neal D.","family":"Shore","sequence":"first","affiliation":[{"name":"START Carolinas\/Carolina Urologic Research Center","place":["Myrtle Beach, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Fizazi","sequence":"additional","affiliation":[{"name":"University of Paris Saclay","place":["Lille, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Thomas","family":"Schweizer","sequence":"additional","affiliation":[{"name":"University of Washington","place":["Seattle, USA"]},{"name":"Fred Hutchinson Cancer Center","place":["Seattle, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Castro","sequence":"additional","affiliation":[{"name":"Hospital Universitario 12 de Octubre","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun A.","family":"Azad","sequence":"additional","affiliation":[{"name":"Peter MacCallum Cancer Centre","place":["Melbourne, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"George","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine","place":["Durham, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine Martins","family":"da Trindade","sequence":"additional","affiliation":[{"name":"Genitourinary Group (LACOG-GU)","place":["Porto Alegre, Brazil"]},{"name":"Instituto D\u2019Or de Pesquisa e Ensino","place":["Fortaleza, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zeng","sequence":"additional","affiliation":[{"name":"Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Shrivastava","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["South San Francisco, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svitlana","family":"Tonkovyd","sequence":"additional","affiliation":[{"name":"Pfizer Poland","place":["Warsaw, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Bock","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["Cambridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srilakshmi","family":"Nekkalapudi","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyun","family":"Tang","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["South San Francisco, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Lin","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Agarwal","sequence":"additional","affiliation":[{"name":"University of Utah","place":["Salt Lake City, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,5,10]]},"reference":[{"key":"e_1_3_8_3_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"key":"e_1_3_8_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncpuro1296"},{"key":"e_1_3_8_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00978-z"},{"key":"e_1_3_8_6_1","doi-asserted-by":"publisher","DOI":"10.17159\/2078-5151\/2021\/v59n4a3327"},{"key":"e_1_3_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2023.101143"},{"key":"e_1_3_8_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0078-z"},{"key":"e_1_3_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.06.039"},{"key":"e_1_3_8_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0086-z"},{"key":"e_1_3_8_11_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-19-1423"},{"key":"e_1_3_8_12_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aah4199"},{"key":"e_1_3_8_13_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci127961"},{"key":"e_1_3_8_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51156-5"},{"key":"e_1_3_8_15_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b01375"},{"key":"e_1_3_8_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-023-02025-6"},{"key":"e_1_3_8_17_1","unstructured":"National Cancer Institute. EZH2 inhibitor PF-06821497. 2024 [cited 2025 May 20]. Available from: https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-drug\/def\/mevrometostat"},{"key":"e_1_3_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.104972"},{"key":"e_1_3_8_19_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.5_suppl.LBA138"},{"key":"e_1_3_8_20_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.5061"},{"key":"e_1_3_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30688-6"},{"key":"e_1_3_8_22_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-14-2666"},{"key":"e_1_3_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.06.011"},{"key":"e_1_3_8_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2214676"},{"key":"e_1_3_8_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(24)01653-2"},{"key":"e_1_3_8_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.08.2308"},{"key":"e_1_3_8_27_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.48707"},{"key":"e_1_3_8_28_1","unstructured":"Cornford P Tilki D van den Bergh RCN et al. EAU - EANM - ESTRO - ESUR - ISUP - SIOG guidelines on prostate cancer. Arnhem the Netherlands: EAU Guidelines Office; 2024 [cited 2025 Jul 15]. Available from: https:\/\/d56bochluxqnz.cloudfront.net\/documents\/full-guideline\/EAU-EANM-ESTRO-ESUR-ISUP-SIOG-Guidelines-on-Prostate-Cancer-2024_2024-04-09-132035_ypmy.pdf"},{"key":"e_1_3_8_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000003452"},{"key":"e_1_3_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.02.018"},{"key":"e_1_3_8_31_1","doi-asserted-by":"publisher","DOI":"10.1530\/erc-21-0002"},{"key":"e_1_3_8_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.13123"},{"key":"e_1_3_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107669"},{"key":"e_1_3_8_34_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA119.008152"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14796694.2026.2667441","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14796694.2026.2667441","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14796694.2026.2667441","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T06:27:49Z","timestamp":1790576869000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14796694.2026.2667441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,10]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,5,15]]}},"alternative-id":["10.1080\/14796694.2026.2667441"],"URL":"https:\/\/doi.org\/10.1080\/14796694.2026.2667441","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-12-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}